NEWSROOM
Press Releases
Six-month outcomes from phase-one trial of anti-inflammatory drug to assess benefit in acute DVT patients demonstrate ‘promise’
The open-label phase of the DEXTERITY-AFP trial investigating the Bullfrog microinfusion...
Data from First Phase of DEXTERITY-AFP Study Unveiled at VEINS Meeting in Las Vegas
LAS VEGAS, NV / ACCESSWIRE / October 30, 2023 / The DEXTERITY-AFP study, led by vascular surgeon...
Late-Breaking Clinical Trial Results Announced at The VEINS 2023
LAS VEGAS, Oct. 30, 2023 /PRNewswire/ -- The VIVA Foundation, a not-for-profit organization...
Mercator MedSystems Announces Publication of Results from TANGO Phase 2 Clinical Trial to Improve Outcomes after Below-Knee Arterial Revascularization
First U.S. Double-Blinded Randomized Controlled Trial to Date Addressing Unmet Needs in Critical...
Mercator MedSystems Announces Receipt of NIH Grant for Research and Development of Local Anti-inflammatory Deep Vein Thrombosis Therapy
January 10, 2022, Emeryville, Calif. – Mercator MedSystems, Inc. (“Mercator” or the “company”),...
Mercator Announces Enrollment of First Patient in DEXTERITY-AFP Clinical Trial Treating Inflammation in Deep Vein Thrombosis
EMERYVILLE, Calif., November 3, 2021 - Mercator MedSystems, Inc. (“Mercator”), a medical...
Updates and Conferences
Mercator Medsystems featured in BTIG’s Analyst Report: Medical Technology and Digital Health:...
Updates in Peripheral Vascular Med Tech
Vascular Breakthroughs, LLC, and Vascular Care Connecticut Announce First New England Enrollment...
